Filing Details

Accession Number:
0000905148-21-000612
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-19 15:00:33
Reporting Period:
2021-08-17
Accepted Time:
2021-08-19 15:00:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439725 Biodesix Inc BDSX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021413 John Patience 2970 Wilderness Place
Suite 100
Boulder CO 80301
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-17 1,604 $7.12 1,912,474 No 4 P Indirect By Patience Enterprises LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Patience Enterprises LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 58,597 Direct
Common Stock 2,811,353 Indirect By John Patience Living Trust dated 7/23/1993
Common Stock 30,000 Indirect By Spouse
Footnotes
  1. The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  2. The reporting person is the sole trustee of John Patience Trust (July 23, 1993).
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.94 to $7.25, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  4. In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 98 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person.
  5. In the Form 4 filed by the Reporting Person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned in Table I was inadvertently overstated by 78 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by the Reporting Person.